
Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic связывание with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump ингибитор for the treatment of acid-related diseases.
Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.